Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Lymphedema 2Neoplasms 1

Interventions

pycnogenols 2Pentoxifylline 2pirfenidone 1pazopanib 1Vitamin E 1Tocopherols 1Technetium Tc 99m Sulfur Colloid 1Surgical Procedures, Operative 1Standard of Care 1Sodium Selenite 1Sodium Chloride 1Sentinel Lymph Node Biopsy 1Radiotherapy 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Methylene Blue 1Mastectomy, Segmental 1Mastectomy 1Manual Lymphatic Drainage 1Lymph Node Excision 1Lipectomy 1Ketoprofen 1Indocyanine Green 1Hyperbaric Oxygenation 1Drug Therapy 1Compression Bandages 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Lymphedema × pycnogenols × Clear all
NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed
2 enrolled

Lymphedema

NCT00064857 2008-04-22

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
26 enrolled

Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡